Novel Coronavirus (COVID-19) and the Thyroid: Frequently Asked Questions - oneGRAVESvoice

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Patient Education

Novel Coronavirus (COVID-19) and the Thyroid: Frequently Asked Questions

key information

source: American Thyroid Association

year: 2020


Novel Coronavirus (COVID-19) and the Thyroid:
Frequently Asked Questions

Over the past days and weeks, the American Thyroid Association® and its members have heard many important concerns raised by both patients and their providers about how the novel coronavirus (COVID-19) pandemic might impact people living with thyroid conditions. Here, we address the most frequently asked questions thus far.

-Are people with autoimmune thyroid disease, such as Hashimoto’s thyroiditis or Graves’ disease, at more risk for acquiring COVID-19 or having a more serious COVID-19 infection?

-Are there any shortages of levothyroxine?

-How do patients taking methimazole for hyperthyroidism tell the difference between a COVID-19 infection or side effects of methimazole?

-How can methimazole be given to patients with critical illness?

-Is it safe to delay a biopsy of my thyroid nodule?

-Are people with thyroid cancer at more risk from COVID-19 because they are immunocompromised?

-Is it safe to delay thyroid cancer surgery because of the current COVID-19 pandemic?

-Is it safe to delay radioactive iodine treatment because of the current COVID-19 pandemic?

read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.